Tutorials › Pharmacokinetic-Pharmacodynamic (PK/PD) Modeling › Defining Sequential and Simultaneous PK/PD Estimands

Sequential Versus Simultaneous PK/PD Estimation · Tutorial 395 of 598

Defining Sequential and Simultaneous PK/PD Estimands

Learn to state the PD quantity being targeted and distinguish a fixed-PK conditional effect from an effect averaged over PK uncertainty and population variability.

Advanced 12 min read

What You'll Learn

  • Distinguish a scientific estimand from the estimator used to calculate it.
  • Define population PD parameters and individual effects conditional on PK values.
  • Express marginal PD effects as averages over PK uncertainty.
  • See why nonlinear PD models can yield different plug-in and marginal effects.
  • Separate a typical population parameter from a population-average response.
  • Identify assumptions and diagnostics relevant to choosing and interpreting a target.

Why the Target Must Be Stated

A PK/PD analysis can report a PD parameter, an individual effect, or an average response over a population. These quantities are related, but they are not interchangeable. For example, a PD effect calculated at a subject’s estimated concentration is conditional on that concentration value. An effect averaged over uncertainty in the subject’s PK parameters is a different target, especially when the PD response is nonlinear in concentration.

The distinction matters when comparing sequential and simultaneous estimation. These are estimation strategies, not estimands by themselves. Either strategy can be used with a clearly specified target, but a sequential analysis that fixes PK estimates naturally produces conditional PD estimates unless the target is explicitly averaged over PK uncertainty. A simultaneous model can estimate shared population parameters while also defining individual or marginal response targets.

Definition: An estimand is the precisely defined quantity an analysis aims to estimate, including the population or subject, treatment or exposure contrast, time point, and averaging rule. An estimator is a rule applied to observed data to estimate that quantity. Changing how PK uncertainty or population variability is averaged can change the estimand, not merely the estimator.

A Notation for the Main Targets

For subject \(i\), let \(C_i(t;\theta_i)\) be the concentration at time \(t\) implied by that subject’s PK parameters \(\theta_i\). Let \(m\{C_i(t;\theta_i),\beta,b_i\}\) be the model’s expected PD response. Here, \(\beta\) denotes population PD parameters and \(b_i\) denotes subject-specific PD deviations when the model includes them. A PD effect is often a contrast between two conditions, such as an exposure condition and a reference condition:

$$ \Delta_i(\theta_i,b_i) = m\{C_i(t;\theta_i),\beta,b_i\} - m\{C_{i,\mathrm{ref}}(t;\theta_i),\beta,b_i\}. $$

The reference might be zero concentration, placebo, or another specified exposure. The contrast and time point must be stated; a parameter such as an Emax or slope is not itself automatically the treatment effect at every concentration.

  • Population PD parameter: a shared parameter such as \(\beta\), defined by the chosen population model. It describes a feature of that model; it is not necessarily an average individual response.
  • Individual conditional effect: \(\Delta_i(\hat\theta_i,b_i)\), evaluated at a specified PK value, often a fitted or estimated value \(\hat\theta_i\). The target is conditional on that value being fixed.
  • PK-uncertainty-marginal effect: an average of the individual effect over a distribution of plausible PK values, such as \(E\{\Delta_i(\theta_i,b_i)\mid D_{\mathrm{PK}}\}\). Here \(D_{\mathrm{PK}}\) denotes the subject’s PK data.
  • Population-average effect: an average over the target population’s distribution of PK and, if present, PD subject effects. The averaging distribution and population must be specified.

A conditional effect and a marginal effect answer different questions. “What is the model-predicted effect at this fixed PK estimate?” is conditional. “What effect is expected when PK uncertainty is accounted for?” is marginal over the specified uncertainty distribution. “What is the average effect in the target population?” additionally requires a population averaging rule.

Worked Example: An Individual Effect Conditional on PK

Suppose a hypothetical Emax model describes the drug-related increase in a PD response, relative to zero concentration, as

$$ \Delta(C)=\frac{E_{\max}C}{EC_{50}+C}. $$

For one hypothetical subject, take \(E_{\max}=12\) response units, \(EC_{50}=3\) mg/L, and a fixed PK estimate that gives \(C=3\) mg/L at the time of interest. The conditional effect is

$$ \Delta(3) = \frac{12\ \text{response units}\times 3\ \text{mg/L}} {3\ \text{mg/L}+3\ \text{mg/L}} = \frac{36}{6} = 6\ \text{response units}. $$

The result is an effect conditional on \(C=3\) mg/L and on the stated PD parameter values. It does not average over uncertainty in the PK parameters that produced that concentration. It also is not, by itself, a population-average effect.

Marginalizing Over PK Uncertainty

Suppose the PK data do not determine a subject’s PK parameters exactly. A marginal target averages the response contrast over a distribution representing that uncertainty. In a Bayesian analysis this may be a posterior distribution conditional on PK data; in another framework it may be a specified sampling or uncertainty distribution. The distribution used must be stated because it defines the average.

Definition: For a subject-level effect \(\Delta_i(\theta_i,b_i)\), the PK-uncertainty-marginal effect conditional on the observed PK data is $$ \Delta_{i,\mathrm{marg}} = \int \Delta_i(\theta_i,b_i)\, p(\theta_i\mid D_{\mathrm{PK}})\,d\theta_i. $$ If PD subject effects are also uncertain and are to be averaged, the integral must include their distribution as well. This target averages the effect over uncertainty; it is not the effect evaluated at the average PK parameter.

The distinction follows directly from the definition of an expectation. A plug-in result substitutes one value, such as a PK estimate, into the response function. A marginal result first evaluates the response across the uncertainty distribution and then averages those responses. In general,

$$ E\{\Delta_i(\theta_i,b_i)\mid D_{\mathrm{PK}}\} \ne \Delta_i\{E(\theta_i\mid D_{\mathrm{PK}}),b_i\}. $$

Equality holds in special cases, including when the effect is linear in the uncertain quantity being averaged. With nonlinear concentration-response functions, the two sides can differ even when the expected concentration is known exactly.

Worked Example: Nonlinearity Changes the Marginal Effect

Continue with the hypothetical Emax model, \(E_{\max}=12\) response units and \(EC_{50}=3\) mg/L. Suppose the PK uncertainty is represented by two equally weighted possible concentrations at the time of interest: \(C=1\) mg/L and \(C=5\) mg/L. The marginal effect is the average of the two model-predicted effects.

At \(C=1\) mg/L:

$$ \Delta(1)=\frac{12\times 1}{3+1}=3.00\ \text{response units}. $$

At \(C=5\) mg/L:

$$ \Delta(5)=\frac{12\times 5}{3+5}=7.50\ \text{response units}. $$

Thus the marginal effect is

$$ \Delta_{\mathrm{marg}} = 0.5(3.00)+0.5(7.50) = 5.25\ \text{response units}. $$

The mean concentration is \(0.5(1)+0.5(5)=3\) mg/L. Plugging that mean into the Emax curve gives

$$ \Delta(3)=\frac{12\times 3}{3+3}=6.00\ \text{response units}. $$

The plug-in effect, \(6.00\) response units, differs from the marginal effect, \(5.25\) response units. The latter is the average of the effects over the stated two-point PK uncertainty distribution. The former is the effect at the mean concentration. Neither calculation is universally preferable: the appropriate one depends on the scientific question.

Population Parameters and Population-Average Effects

A population PD parameter and an average effect in a population are also distinct. A shared parameter may describe the typical response function, while a population-average effect averages individual responses over the population’s PK and PD variability. Those individual values need not be independent: subjects with different exposures may also have different PD effects. Consequently, the population-average response depends on the joint distribution specified by the model, not just on a typical parameter and a typical concentration.

For example, if individual effects follow \(\Delta_i=(\beta+b_i)C_i\), where the population mean of \(b_i\) is zero, then \(\beta\) is the population mean slope. The population-average effect is \(E\{(\beta+b_i)C_i\}\). It equals \(\beta E(C_i)\) only under additional conditions, such as zero covariance between \(b_i\) and \(C_i\). This is a definition-based distinction, not a claim that either target is always the desired one.

Worked Example: Typical Slope Versus Average Population Effect

Consider a hypothetical target population represented by two equally weighted subjects. Their concentrations are \(C_1=1\) mg/L and \(C_2=5\) mg/L. Their individual slopes are \(2\) and \(4\) response units per mg/L, respectively. The population mean slope is

$$ \beta=\frac{2+4}{2}=3\ \text{response units per mg/L}. $$

The mean concentration is \((1+5)/2=3\) mg/L, so the typical-slope-at-mean-concentration calculation is

$$ \beta\,\bar C = 3\ \frac{\text{response units}}{\text{mg/L}} \times 3\ \text{mg/L} = 9\ \text{response units}. $$

But the individual effects are \(2\times1=2\) response units and \(4\times5=20\) response units. Their population average is

$$ \frac{2+20}{2}=11\ \text{response units}. $$

Here the higher slope occurs in the subject with higher concentration, so the population-average effect is \(11\), not \(9\) response units. The slope parameter, the effect at a representative concentration, and the average of individual effects are different targets. The target population and its joint distribution of slopes and concentrations determine which average is meaningful.

Sequential and Simultaneous Estimation: What Changes?

In sequential estimation, PK parameters or concentrations are first estimated and then supplied to a PD analysis. If those values are treated as fixed, the PD target is conditional on them. A simultaneous analysis estimates PK and PD quantities within a joint model, but that fact alone does not define whether the reported result is a population parameter, a subject-specific conditional effect, or a marginal effect. The analysis must still specify the target.

If two approaches use the same correctly specified model and target the same parameter, their estimators may differ while the estimand remains the same. Conversely, comparing a conditional plug-in effect from one analysis with a population-average effect from another compares different quantities, even if both are labelled “the PD effect.” A joint model can also report a parameter such as \(\beta\) without that parameter being a marginal clinical response contrast.

Reported quantityWhat is held fixed or averaged?Interpretation
Population PD parameter \(\beta\)Defined by the population PD modelA shared model parameter, such as a typical slope or Emax
Individual conditional effectEvaluated at specified subject PK values and PD effectsPredicted contrast for that subject conditional on those values
PK-marginal individual effectAveraged over uncertainty in subject PK valuesExpected subject effect under the stated PK uncertainty distribution
Population-average effectAveraged over the target population’s PK and PD variabilityMean contrast in the specified population and conditions

Assumptions, Diagnostics, and Limitations

Each target is meaningful only relative to its assumptions. A conditional effect assumes the fixed PK values and the PD model are suitable for the stated subject and time. A PK-marginal effect requires a defensible uncertainty distribution for PK parameters and a response model that is adequate across the values receiving weight. A population-average effect additionally requires a defined target population and an appropriate distribution for its subject-level characteristics.

Before interpreting a result, check whether the report identifies the exposure contrast, time point, target population, and averaging rule. Check whether a quantity described as marginal was actually averaged over the relevant distribution, rather than evaluated at a mean estimate. For a population average, consider whether the model’s assumed relationship between PK and PD variability is plausible. Predictions that rely heavily on exposure values outside the observed data also deserve caution: the mathematical target may be defined, but the data may provide weak support for it.

A common mistake is to say, “The simultaneous fit gives the population effect, while the sequential fit gives the individual effect.” That confuses estimation strategy with estimand. Either strategy can target different quantities depending on the model and the reported functional. The correction is to state the estimand explicitly and then explain how the fitted analysis estimates it. Another mistake is to substitute mean exposure into a nonlinear PD function and call the result the mean effect. As the Emax example showed, the mean of predicted effects need not equal the prediction at mean exposure.

No single target is always best. A conditional effect can answer a subject-specific prediction question but omit uncertainty from PK estimation. A marginal effect accounts for a specified distribution of PK uncertainty but depends on that distribution. A population-average effect can support population-level interpretation, yet may conceal important subject heterogeneity. The target should follow the scientific question, and conclusions should be limited to the population, contrasts, and conditions used to define it.

Check Your Understanding

For each question, identify the target or calculate the requested quantity.

  1. A PD effect is evaluated at a fixed concentration estimate of 4 mg/L. Is it conditional or marginal over PK uncertainty?
  2. Under the Emax model with \(E_{\max}=10\) response units and \(EC_{50}=2\) mg/L, calculate the effect at \(C=2\) mg/L.
  3. A PK uncertainty distribution assigns equal weight to \(C=0\) and \(C=4\) mg/L. Under the same Emax model, calculate the marginal effect and compare it with the effect at mean concentration.
  4. Why can the population mean slope multiplied by mean concentration differ from the population-average effect?

Solutions. (1) It is conditional on the fixed concentration value; no averaging over PK uncertainty is described. (2) \(\Delta(2)=10\times2/(2+2)=5.00\) response units. (3) The effects are \(\Delta(0)=0\) and \(\Delta(4)=10\times4/(2+4)=6.67\) response units, so the marginal effect is \(0.5(0)+0.5(6.67)=3.33\) response units. Mean concentration is 2 mg/L, giving \(\Delta(2)=5.00\) response units; the results differ because the Emax response is nonlinear. (4) The individual slope and concentration can vary together. The average product need not equal the product of the averages; equality requires conditions on their dependence, such as zero covariance.

Clinical Biostats